Daisuke Ito

Summary

Affiliation: University of Minnesota
Country: USA

Publications

  1. ncbi request reprint Canine lymphoma as a comparative model for human non-Hodgkin lymphoma: recent progress and applications
    Daisuke Ito
    Department of Veterinary Clinical Sciences, University of Minnesota, St Paul, MN, USA Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA Electronic address
    Vet Immunol Immunopathol 159:192-201. 2014
  2. pmc CD40 ligand is necessary and sufficient to support primary diffuse large B-cell lymphoma cells in culture: a tool for in vitro preclinical studies with primary B-cell malignancies
    Daisuke Ito
    Masonic Cancer Center, University of Minnesota, Minneapolis, MN 5455, USA
    Leuk Lymphoma 53:1390-8. 2012
  3. pmc Exclusion of cytoplasmic fragments in flow cytometric analysis of lymph node samples from dogs with lymphoma using membrane-permeable violet laser-excitable DNA-binding fluorescent dye (DyeCycle Violet)
    Daisuke Ito
    Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA
    Vet Clin Pathol 39:494-8. 2010
  4. doi request reprint A tumor-related lymphoid progenitor population supports hierarchical tumor organization in canine B-cell lymphoma
    D Ito
    Department of Veterinary Clinical Sciences, College of Veterinary Medicine, University of Minnesota, St Paul, MN, USA
    J Vet Intern Med 25:890-6. 2011
  5. ncbi request reprint Isolation and characterization of canine natural killer cells
    Helen T Michael
    Department of Veterinary Clinical Sciences, College of Veterinary Medicine, University of Minnesota, 1352 Boyd Avenue, St Paul, MN 55108, United States
    Vet Immunol Immunopathol 155:211-7. 2013
  6. pmc Parenchymal signal intensity in 3-T body MRI of dogs with hematopoietic neoplasia
    Daniel A Feeney
    Department of Veterinary Clinical Sciences, University of Minnesota, St Paul, Minnesota, USA
    Comp Med 63:174-82. 2013
  7. doi request reprint Molecular characterization of canine BCR-ABL-positive chronic myelomonocytic leukemia before and after chemotherapy
    Sarah Culver
    Department of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, USA
    Vet Clin Pathol 42:314-22. 2013
  8. ncbi request reprint Development of a novel anti-canine CD20 monoclonal antibody with diagnostic and therapeutic potential
    Daisuke Ito
    Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA
    Leuk Lymphoma . 2014

Detail Information

Publications8

  1. ncbi request reprint Canine lymphoma as a comparative model for human non-Hodgkin lymphoma: recent progress and applications
    Daisuke Ito
    Department of Veterinary Clinical Sciences, University of Minnesota, St Paul, MN, USA Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA Electronic address
    Vet Immunol Immunopathol 159:192-201. 2014
    ....
  2. pmc CD40 ligand is necessary and sufficient to support primary diffuse large B-cell lymphoma cells in culture: a tool for in vitro preclinical studies with primary B-cell malignancies
    Daisuke Ito
    Masonic Cancer Center, University of Minnesota, Minneapolis, MN 5455, USA
    Leuk Lymphoma 53:1390-8. 2012
    ..We conclude that this system has broad applications for in vitro preclinical development for B-cell malignancies...
  3. pmc Exclusion of cytoplasmic fragments in flow cytometric analysis of lymph node samples from dogs with lymphoma using membrane-permeable violet laser-excitable DNA-binding fluorescent dye (DyeCycle Violet)
    Daisuke Ito
    Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA
    Vet Clin Pathol 39:494-8. 2010
    ..These cytoplasmic fragments interfere with accurate gating of target cells and quantification protocols used for flow cytometry because of their variable size and expression of lymphoid cell surface antigens on their membranes...
  4. doi request reprint A tumor-related lymphoid progenitor population supports hierarchical tumor organization in canine B-cell lymphoma
    D Ito
    Department of Veterinary Clinical Sciences, College of Veterinary Medicine, University of Minnesota, St Paul, MN, USA
    J Vet Intern Med 25:890-6. 2011
    ..This model is clinically important, as TICs are promising targets for cancer therapies. However, TICs in spontaneous B-cell lymphoma have not been conclusively identified...
  5. ncbi request reprint Isolation and characterization of canine natural killer cells
    Helen T Michael
    Department of Veterinary Clinical Sciences, College of Veterinary Medicine, University of Minnesota, 1352 Boyd Avenue, St Paul, MN 55108, United States
    Vet Immunol Immunopathol 155:211-7. 2013
    ..The data show that cells meeting the criteria for NK cells in other species, i.e., non-T, non-B lymphocytes with cytotoxic activity, can be expanded from canine PBMC by T-cell depletion and culture with cytokines or feeder cells. ..
  6. pmc Parenchymal signal intensity in 3-T body MRI of dogs with hematopoietic neoplasia
    Daniel A Feeney
    Department of Veterinary Clinical Sciences, University of Minnesota, St Paul, Minnesota, USA
    Comp Med 63:174-82. 2013
    ....
  7. doi request reprint Molecular characterization of canine BCR-ABL-positive chronic myelomonocytic leukemia before and after chemotherapy
    Sarah Culver
    Department of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, USA
    Vet Clin Pathol 42:314-22. 2013
    ..Further understanding of the genetic aberrations involved in canine leukemia may be crucial to improve treatment protocols...
  8. ncbi request reprint Development of a novel anti-canine CD20 monoclonal antibody with diagnostic and therapeutic potential
    Daisuke Ito
    Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA
    Leuk Lymphoma . 2014
    ..In summary, we have established a novel anti-canine CD20 mAb that is useful as a diagnostic tool to phenotype B-cells, and which could be integrated as a tool for passive immunotherapy to treat dogs with B-cell disorders...